| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $146.1M | +0.6% |
| R&D Expense | $125.6M | -12.3% |
| SG&A Expense | $105.2M | -8.9% |
| Operating Income | -$90.7M | +24.1% |
| Pre-tax Income | -$196.0M | -156.7% |
| Income Tax | $43K | -24.6% |
| Net Income | -$196.0M | -156.5% |
| EPS (Basic) | -$17.93 | -2746.0% |
| EPS (Diluted) | -$17.93 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.5M | -3.1% |
| Accounts Receivable | $26.2M | -14.9% |
| Inventory | $4.0M | -14.8% |
| Current Assets | $103.1M | -34.1% |
| Total Assets | $108.4M | -34.1% |
| Current Liabilities | $92.1M | -0.2% |
| Total Liabilities | $401.3M | +14.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.4M | +40.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $43.4M | -54.6% |
| Financing Cash Flow | $30.0M | -27.8% |
| Free Cash Flow | -$75.4M | +40.9% |
| -1828.0% |
| Stockholders' Equity |
| -$292.9M |
| -57.5% |